Rubicon Research Ltd
Rubicon Research Ltd Share Price Today: Live Updates & Key Insights
Get insights on Rubicon Research Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Rubicon Research Ltd Share Price Chart
RUBICON at 04 Feb 2026 03:59 PM Pharmaceuticals
767.55 +44.30(+6.13%)
Lowest Today 728.60
Highest Today 788.85
Today's Open 747.85
Prev. Close 723.25
52 Week High 887.95
52 Week Low 571.00
Rubicon Research Ltd Fundamentals
Traded Volume: 1,34,644
Market Cap(Cr): 12,645
Avg Traded Price 763.19
1 Year return %
Upper Circuit 788.9
Lower Circuit 728.6
P/E TTM 0.00
P/B Ratio 20.567
Traded Value(Cr) 1033.46
EPS TTM NaN
Book value/Share 35.100
Dividend Yield 1Y 0.00%
Rubicon Research Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Rubicon Research Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Rubicon Research Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W +18.26%
1M +16.23%
3M 0.00%
1Y 0.00%
YTD +6.71%
Rubicon Research Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Rubicon Research Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 3.58L
Day Before Yesterday 1.05L
1W Avg 1.37L
1M Avg 1.70L
3M Avg 3.33L
Rubicon Research Ltd Technical Details
Rubicon Research Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 702
Support 2 681
Support 3 665
Pivot Point : 718
Resistance 1 739
Resistance 2 755
Resistance 3 776
Rubicon Research Ltd Corporate Actions
Rubicon Research Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Rubicon Research Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by RUBICON
Bonus
No Bonus has been declared by RUBICON
Splits
No Split has been declared by RUBICON
Others
Rights No Rights has been declared by RUBICON
Rubicon Research Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Rubicon Research Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Rubicon Research Ltd's relative performance and valuation against major competitors.
Stock Name Granules India Ltd ₹582.70 (+1.91%) M. Cap (Cr) 141.40 1 Yr Return (%) +4.72% P/E (TTM) 25.92 PB Ratio 3.55
Stock Name Cohance Lifesciences Ltd ₹366.75 (-3.65%) M. Cap (Cr) 140.31 1 Yr Return (%) -66.84% P/E (TTM) 56.61 PB Ratio 3.70
Stock Name OneSource Specialty Pharma Ltd ₹1213.70 (+3.07%) M. Cap (Cr) 139.07 1 Yr Return (%) NaN% P/E (TTM) 692.05 PB Ratio 2.36
Stock Name Rubicon Research Ltd ₹773.95 (+7.21%) M. Cap (Cr) 127.51 1 Yr Return (%) NaN% P/E (TTM) PB Ratio 19.66
Stock Name Alivus Life Sciences Ltd ₹939.05 (-0.88%) M. Cap (Cr) 115.26 1 Yr Return (%) -20.17% P/E (TTM) 21.20 PB Ratio 3.82
Stock Name Sanofi Consumer Healthcare India Ltd ₹4298.60 (-2.06%) M. Cap (Cr) 99.00 1 Yr Return (%) NaN% P/E (TTM) 45.43 PB Ratio 36.26
Stock Name Viyash Scientific Ltd ₹216.55 (+1.81%) M. Cap (Cr) 94.55 1 Yr Return (%) +35.20% P/E (TTM) 210.81 PB Ratio 11.18
Rubicon Research Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Rubicon Research Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 29.65 Mar 2024 83.20 Mar 2023 -79.02 Mar 2022 -37.12
PARTICULARS Investing Activities Mar 2025 -10.03 Mar 2024 -130.49 Mar 2023 -33.95 Mar 2022 -86.19
PARTICULARS Financing Activities Mar 2025 -34.05 Mar 2024 45.86 Mar 2023 123.65 Mar 2022 65.22
PARTICULARS Net Cash Flow Mar 2025 -14.62 Mar 2024 -1.29 Mar 2023 12.19 Mar 2022 -49.08
Rubicon Research Ltd Shareholding Pattern
This shows the ownership breakdown of Rubicon Research Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 59.99%
Public 22.57%
Other Institutions 2.84%
FII 7.99%
Mutual Funds 6.61%
About Rubicon Research Ltd
Rubicon Research Limited was incorporated on May 6, 1999, as a Private Company as `Rubicon Consultants Private Limited', with the RoC. Subsequently, the Company's name was changed from `Rubicon Consultants Private Limited' to `Rubicon Research Private Limited' to which a fresh Certificate of Incorporation was issued by the RoC dated September 2, 2002. The Company's status got converted from a Private Company to a Public Company, the name was changed from `Rubicon Research Private Limited' to `Rubicon Research Limited'. A fresh Certificate of Incorporation dated July 23, 2024 was issued by the Central Processing Centre, Manesar, Haryana. Rubicon Research is an integrated pharmaceutical company with business encompassing the entire value chain in the research, development and production of pharmaceutical products. The Company is driven by innovation through focused research and development, with an increasing portfolio of specialty products and drug-device combination products targeting regulated markets, particularly, the United States. It has obtained its GMP manufacturing facilities at Ambernath and Satara in Maharashtra.The Company commenced manufacturing of certain special drugs in Ambernath Manufacturing Facility in 2011. In 2016, the Company acquired majority stake by ECP III Pte Ltd. Further, it acquired majority stake by General Atlantic Singapore RR Pte. Ltd., from ECP III Pte. Ltd. in 2019. In 2021, the Company acquired the business of Meditab Specialities Limited on slump sale as a going concern. In FY 2024, the Company acquired Validus, a New Jersey headquartered marketer of brand name formulation products in the US. It commenced the manufacturing of nasal products at Ambernath Plant in 2024. The Company has acquired Pithampur Manufacturing Facility from Alkem Laboratories Ltd in 2025. The Company came up with its initial public offering of 28,405,841 equity shares of face value of Re 1 each, by raising funds aggregating to Rs 1378 crores, comprising a fresh issue of 10,313,058 equity shares aggregating to Rs 500 crores and the offer for sale of 18,092,783 equity shares aggregating to Rs 878 crores on October 13, 2025.
Registered office Medone House B-75 Road No.33, Wagle Estate, Thane (West), Maharashtra, 400604
FAX :022 6141 4000
Background
Incorporation Year 1999
Face Value ₹1.00
Market Lot 1
FAQs on Rubicon Research Ltd
How to buy Rubicon Research Ltd shares on NSE?
To buy Rubicon Research Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Rubicon Research Ltd share price today?
The Rubicon Research Ltd share price on NSE is ₹767.55 today.
What is the market cap of Rubicon Research Ltd on NSE?
The company has a market capitalization of ₹12645.41.
What is the PE & PB ratio of Rubicon Research Ltd?
PE is N/A and PB is 20.567.
What is the 52 Week High and Low of Rubicon Research Ltd shares?
Rubicon Research Ltd stock price high: ₹887.95 Rubicon Research Ltd stock price low: ₹571.